Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: A meta-analysis
- 1 January 2001
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 138 (1) , 26-32
- https://doi.org/10.1067/mpd.2001.110527
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- New approaches to the treatment of congenital adrenal hyperplasia.JAMA, 1997
- Growth of Patients with 21-Hydroxylase Deficiency: An Analysis of the Factors Influencing Adult HeightPediatric Research, 1997
- The use of adrenalectomy as a treatment for congenital adrenal hyperplasiaJournal of Clinical Endocrinology & Metabolism, 1996
- Adult height in women with early‐treated congenital adrenal hyperplasia (21‐hydroxylase type): relation to body mass index in earlier childhoodActa Paediatrica, 1995
- The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH)Acta Endocrinologica, 1986
- Patterns of growth from birth to maturity in infants and children with congenital adrenal hyperplasiaActa Endocrinologica, 1986
- Adult Height and Fertility in Men with Congenital Virilizing Adrenal HyperplasiaNew England Journal of Medicine, 1978
- LINEAR GROWTH AND PUBERTAL DEVELOPMENT IN TREATED CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCYClinical Endocrinology, 1977
- Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effects on height, sexual maturation, and fertilityThe Journal of Pediatrics, 1977
- Experience with long-term therapy in congenital adrenal hyperplasiaThe Journal of Pediatrics, 1974